PerkinElmer elects Dr Sylvie Grégoire to its Board of Directors

Dr Grégoire is currently a Board member of Galenica and also served for five years on the Board of Cubist Pharmaceuticals


The appointment is effective form February 6, 2015

PerkinElmer has announced that Dr Sylvie Grégoire has been elected to its Board of Directors, effective February 6, 2015.

"It is with great enthusiasm that we welcome Dr Sylvie as the newest member of our Board. Her extensive experience gained through global leadership positions within top pharmaceutical and biotechnology companies will prove highly valuable in helping oversee the strategic direction of the company," said Mr Robert Friel, chairman and CEO, PerkinElmer.

With nearly 30 years of industry experience, Dr Grégoire most recently served as the President of Human Genetic Therapies for Shire for seven years.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email